Current Valuation
$8.0M
As of June 21, 2024
Total Funding Raised
$14.7M
Last Round
Early Stage VC

$310.0K

Last Funding
Jun 2024

Funding date

Capital Efficiency
0.54x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

New Frontier Bio is currently valued at $8.0M as of June 21, 2024. The company has raised a total of $14.7M in funding.

Capital Efficiency

With a capital efficiency ratio of 0.54x, New Frontier Bio has achieved a valuation that is 0.54 times the total capital raised. This metric indicates room for improvement in capital deployment.

Investment Perspective

New Frontier Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track New Frontier Bio Valuation Updates

Get notified when New Frontier Bio raises new funding or valuation changes

What is New Frontier Bio Worth in 2025?

As of 2025, New Frontier Bio is valued at $8.0M, based on the company's Early Stage VC funding round in June 21, 2024. This valuation positions New Frontier Bio as one of the leading private companies in the sector.

New Frontier Bio Valuation History

New Frontier Bio's funding history demonstrates steady growth and investor confidence.

How New Frontier Bio Valuation is Determined

Private company valuations like New Frontier Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

New Frontier Bio Valuation FAQs

Is New Frontier Bio profitable?

New Frontier Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does New Frontier Bio's valuation compare to competitors?

New Frontier Bio is valued at $8.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will New Frontier Bio IPO?

New Frontier Bio has not announced plans for an initial public offering. Until an IPO, investors can access New Frontier Bio shares through secondary market platforms.